202 related articles for article (PubMed ID: 7581276)
1. Immunochemical characterisation and epitope mapping of a novel fimbrial protein (Pg-II fimbria) of Porphyromonas gingivalis.
Ogawa T; Yasuda K; Yamada K; Mori H; Ochiai K; Hasegawa M
FEMS Immunol Med Microbiol; 1995 Jun; 11(3):247-55. PubMed ID: 7581276
[TBL] [Abstract][Full Text] [Related]
2. The potential protective immune responses to synthetic peptides containing conserved epitopes of Porphyromonas gingivalis fimbrial protein.
Ogawa T
J Med Microbiol; 1994 Nov; 41(5):349-58. PubMed ID: 7966208
[TBL] [Abstract][Full Text] [Related]
3. Distribution and immunochemical specificities of fimbriae of Porphyromonas gingivalis and related bacterial species.
Ogawa T; Mukai T; Yasuda K; Shimauchi H; Toda Y; Hamada S
Oral Microbiol Immunol; 1991 Dec; 6(6):332-40. PubMed ID: 1726543
[TBL] [Abstract][Full Text] [Related]
4. Mapping of murine Th1 and Th2 helper T-cell epitopes on fimbriae from Porphyromonas gingivalis.
Ogawa T; Uchida H; Yasuda K
J Med Microbiol; 1995 Mar; 42(3):165-70. PubMed ID: 7533839
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of a putative fimbrial protein/receptor of Porphyromonas gingivalis.
Dashper SG; O'Brien-Simpson NM; Bhogal PS; Franzmann AD; Reynolds EC
Aust Dent J; 1998 Apr; 43(2):99-104. PubMed ID: 9612983
[TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune responses to the fimbriae of Porphyromonas gingivalis and their synthetic peptides.
Ogawa T; Ogo H; Uchida H; Hamada S
J Med Microbiol; 1994 Jun; 40(6):397-402. PubMed ID: 7911839
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of a minor fimbria from Porphyromonas gingivalis.
Hamada N; Sojar HT; Cho MI; Genco RJ
Infect Immun; 1996 Nov; 64(11):4788-94. PubMed ID: 8890240
[TBL] [Abstract][Full Text] [Related]
8. Identification of linear antigenic sites on the Porphyromonas gingivalis 43-kDa fimbrillin subunit.
Brant EE; Sojar HT; Sharma A; Bedi GS; Genco RJ; De Nardin E
Oral Microbiol Immunol; 1995 Jun; 10(3):146-50. PubMed ID: 7567063
[TBL] [Abstract][Full Text] [Related]
9. Fimbriae of Porphyromonas gingivalis induce opsonic antibodies that significantly enhance phagocytosis and killing by human polymorphonuclear leukocytes.
Fan Q; Sims T; Sojar H; Genco R; Page RC
Oral Microbiol Immunol; 2001 Jun; 16(3):144-52. PubMed ID: 11358536
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a novel secondary fimbrial protein from Porphyromonas gingivalis strain 381.
Arai M; Hamada N; Umemoto T
FEMS Microbiol Lett; 2000 Dec; 193(1):75-81. PubMed ID: 11094282
[TBL] [Abstract][Full Text] [Related]
11. Molecular and antigenic similarities of the fimbrial major components between Porphyromonas gulae and P. gingivalis.
Hamada N; Takahashi Y; Watanabe K; Kumada H; Oishi Y; Umemoto T
Vet Microbiol; 2008 Apr; 128(1-2):108-17. PubMed ID: 17977673
[TBL] [Abstract][Full Text] [Related]
12. Molecular interactions of Porphyromonas gingivalis fimbriae with host proteins: kinetic analyses based on surface plasmon resonance.
Amano A; Nakamura T; Kimura S; Morisaki I; Nakagawa I; Kawabata S; Hamada S
Infect Immun; 1999 May; 67(5):2399-405. PubMed ID: 10225901
[TBL] [Abstract][Full Text] [Related]
13. Conservation of fimbriae and the hemagglutinating adhesin HA-Ag2 among Porphyromonas gingivalis strains and other anaerobic bacteria studied by epitope mapping analysis.
Du L; Pellen-Mussi P; Chandad F; Mouton C; Bonnaure-Mallet M
Clin Diagn Lab Immunol; 1997 Nov; 4(6):711-4. PubMed ID: 9384294
[TBL] [Abstract][Full Text] [Related]
14. Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae.
Inaba H; Nakano K; Kato T; Nomura R; Kawai S; Kuboniwa M; Ishihara K; Ooshima T; Amano A
Oral Microbiol Immunol; 2008 Feb; 23(1):29-35. PubMed ID: 18173795
[TBL] [Abstract][Full Text] [Related]
15. Maturation of the Mfa1 Fimbriae in the Oral Pathogen
Lee JY; Miller DP; Wu L; Casella CR; Hasegawa Y; Lamont RJ
Front Cell Infect Microbiol; 2018; 8():137. PubMed ID: 29868494
[TBL] [Abstract][Full Text] [Related]
16. Prior exposure of mice to Fusobacterium nucleatum modulates host response to Porphyromonas gingivalis.
Choi J; Borrello MA; Smith E; Cutler CW; Sojar H; Zauderer M
Oral Microbiol Immunol; 2001 Dec; 16(6):338-44. PubMed ID: 11737656
[TBL] [Abstract][Full Text] [Related]
17. Molecular and immunological characterization of the fimbriae of Porphyromonas gingivalis.
Hamada S; Fujiwara T; Morishima S; Takahashi I; Nakagawa I; Kimura S; Ogawa T
Microbiol Immunol; 1994; 38(12):921-30. PubMed ID: 7723684
[No Abstract] [Full Text] [Related]
18. Purification and characterization of a fimbrial protein from Porphyromonas salivosa ATCC 49407.
Koyata Y; Watanabe K; Toyama T; Sasaki H; Hamada N
J Vet Med Sci; 2019 Jun; 81(6):916-923. PubMed ID: 31019151
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the immunodominant antigens of Porphyromonas gingivalis 381 in high-responder patients.
Boutsl EA; Koseki T; Nishihara T; Ishikawa I
Oral Microbiol Immunol; 1996 Aug; 11(4):236-41. PubMed ID: 9002875
[TBL] [Abstract][Full Text] [Related]
20. Immunization with fimbrial protein and peptide protects against Porphyromonas gingivalis-induced periodontal tissue destruction.
Evans RT; Klausen B; Genco RJ
Adv Exp Med Biol; 1992; 327():255-62. PubMed ID: 1363504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
